Get Yahoo! Toolbar - Protect your PC
Yahoo!
My Yahoo!
Mail
Search
Search
Sign In
New User?
Sign Up
Finance Home
-
Help
Finance Home
Business News
India Business
World Business
RSS Feeds
Investing
Stocks
Currency
Mutual Funds
Personal Finance
Mutual Funds
Taxes
Insurance
Loans
NRI Corner
My Portfolios
Portfolio Manager
Transaction Manager
Sign In to Create/Edit My Portfolios
Get Quotes:
Get Quotes
Fri, Nov 27, 2009, 1:30PM IST
Home
>
Investing
>
MJN
> Summary
More on MJN
Quotes
Summary
Options
Historical Prices
Charts
Basic Chart
Technical Chart
News
Headlines
Company Events
Company
Profile
Key Statistics
SEC Filings
Competitors
Industry
Analyst Coverage
Analyst Opinion
Analyst Estimates
Research Reports
Star Analysts
Ownership
Major Holders
Insider Trans.
Insider Roster
Financials
Income Statement
Balance Sheet
Cash Flow
Mead Johnson Nutrition Company
(MJN)
44.94
USD
0.00
(0.00%)
On
Nov 26
Mead Johnson Nutrition Company
(NYSE:MJN) Delayed quote data
1d
5d
3m
6m
1y
Last Trade:
44.94
USD
Trade Time:
Nov 26
Change:
0.00
(0.00%)
Prev Close:
44.94
Open:
N/A
Bid:
N/A
Ask:
N/A
1y Target Est:
44.79
Day's Range:
N/A - N/A
52wk Range:
25.72 - 50.35
Volume:
0
Avg Vol
(3m)
:
988,735
Market Cap:
9.19B
P/E
(ttm)
:
22.62
EPS
(ttm)
:
1.99
Div & Yield:
0.50 (1.11%)
Add MJN to Portfolio
Download Data
HEADLINES
Bristol-Myers Squibb Sees Perfect Timing to Divest Huge Mead Johnson Nutrition Stake
- Seeking Alpha - Thu 1:46PM
Is LinkedIn Linking to an IPO?
- Motley Fool - Wed, Nov 25
Abbott Laboratories, Mead Johnson Nutrition: Money Flow Leaders (ABT, MJN)
- The Wall Street Journal Online - Mon, Nov 23
CORRECTED - DEALTALK-Nestle ponders Cadbury for the price of a KitKat
- Reuters - Mon, Nov 23
[$$] Investors, Beware
- Barrons.com - Sat, Nov 21
Big Pharma Mergers: Good News Or Bad?
- Investor's Business Daily - Sat, Nov 21
UPDATE - Rio Tinto unit Cloud Peak IPO prices below range
- Reuters - Fri, Nov 20
Kraft Remains in Pole Position for Cadbury Despite Hershey/Ferrero Rumors
- Seeking Alpha - Thu, Nov 19
Up 80%, It's Time to Sell
- Motley Fool - Wed, Nov 18
[$$] Bristol Needs to Walk Before It Can Run
- The Wall Street Journal Online - Tue, Nov 17
REFILE-UPDATE - Bristol-Myers shares rise on plan to divest Mead
- Reuters - Tue, Nov 17
Biotech Stocks: Bristol-Myers, Merck lead drug stocks higher
- MarketWatch - Tue, Nov 17
» More Headlines for MJN...
ANALYST
EPS Est (next year)
(Dec-09)
:
2.24
EPS Est (in 2 years)
(Dec-10)
:
2.46
Avg Rec (current)*:
2.7
PEG Ratio:
2.15
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
» Analyst Opinion
» Estimates
BUSINESS SUMMARY
Mead Johnson Nutrition Company manufactures and markets infant formula and childrens nutrition products in North America, Latin America, Europe, and the Asia-Pacific.
» Full Company Profile